期刊文献+

犬小口径组织工程化血管移植 被引量:1

Implantation of canine tissue engineering small-diameter blood vessel
下载PDF
导出
摘要 目的研究利用小口径组织工程化血管进行血管移植的可能性。方法来源于骨髓间充质干细胞分化的血管平滑肌样细胞和血管内皮样细胞分层种植于胶原包埋的PGA复合支架上;将复合体种植于动物皮下构建初级组织工程化血管,然后移植组织工程化血管于股动脉,行相关检查,了解移植后血管的特点及细胞来源。结果组织工程化血管移植物通畅,管腔无瘤样扩张,血管搏动佳,内膜光滑,无血栓形成。HE染色见血管壁和正常生理性血管壁的结构相似,分内膜、中膜和外膜三层;免疫荧光观察证实血管壁细胞来源于所种植的种子细胞。结论组织工程血管可以移植于动物体内,该复合体具有与天然血管相似的结构和功能。 Objective To study the possibility of small diameter TEBV implantation into artery by surgical operation. Methods The mixture of seed cells and scaffold were produced by seeding of vascular smooth muscle-like cells and vascular endothelium-like cells derived from bone marrow mesenchymal stem cells on PGA/collagen scaffold. The cell scaffold mixture was subcutaneously implanted into donor dogs for 8 weeks. The TEBV grafts were used to replace a segment of femoral artery. Results In TEBVs grafts group, the grafts were patent and covered with endothelium-like cells, and there was no thrombus formation in the vessels. Histological analysis of the tissue engineering blood vessel wall also showed a typical artery structure, including endothelium, media and adventitia. Two weeks after implantation, the labeled seed ceils by Brdu were found in the three layers of the vessel wall too. Conclusion The tissue engineering vessel may be used to replace natural arteries, the architecture and function of the mixture resembles those of the natural arteries.
出处 《基础医学与临床》 CSCD 北大核心 2009年第4期371-374,共4页 Basic and Clinical Medicine
基金 首都发展基金(2002307) 协和医院基金项目(2001/200240 2002207*)
关键词 组织工程化血管 移植物 tissue engineering blood vessel (TEBV) graft
  • 相关文献

参考文献8

  • 1MacNeill BD,Pomerantseva I,Lowe HC ,et al. Toward a new blood vessel[ J ]. Vasc Med, 2002, 7:241 - 246.
  • 2Seifalian AM, Tiwari A, Hamilton G, et al. Improvement the clinical patency of prosthetic vascular and coronary bypass grafts:the role of seeding and tissue engineering [ J ]. Artif Organs, 2002, 26 (4) :307 - 320.
  • 3杜振宗,任华,张超纪,马国涛,刘洪生.体外构建组织工程化小口径血管模型[J].基础医学与临床,2006,26(2):192-196. 被引量:6
  • 4Drab M,Haller H, Bychkov R, et al. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells:a retinoie acid and db-cAMP in vitro differentiation [J]. FASEB J, 1997, 11(11):905-915.
  • 5Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors[J]. J Cell Mol Med, 2007, 11 (5) :1012 - 1030.
  • 6张超纪,任华,杜振宗,马国涛,刘洪生.成人骨髓间充质干细胞定向诱导为血管内皮样细胞[J].基础医学与临床,2005,25(10):901-905. 被引量:8
  • 7Hongkun Zhang, Shiping Han, Hua Feng,et al. Induction of bone marrow CD3d^+ cells and endothelialization of polytetrafluoroethylene prostheses[ J]. ANZ Journal of Surgery, 2007, 77(6):469-473.
  • 8Niklason LE, Abbott W, Gao J, et al. Morphologic and mechanical characteristics of engineered bovine arteries F[J]. J Vasc Surg, 2001, 33(3) :628 -638.

二级参考文献23

  • 1Schaner PJ, Martin ND, Tulenko TN, et al. Decellularized vein as a potential scaffold for vascular tissue engincering [J].J Vase Surg,2004,40(1):146-153.
  • 2Cummings CL, Gawlitta D, Nerem RM, et al. Properties of engineered vascular constructs made from collagen, fibrin, andcollagen-fibrin mixtures [J]. Biomaterials, 2004,25(17) :3699- 3706.
  • 3Heyligers JM, Arts CH, Verhagen H J, et al. Improving smalldiameter vascular grafts: from the application of an endothelialcell lining to the construction of a tissue-engineered blood vessel[J]. Ann Vasc Surg, 2005,19(3) :448 - 456.
  • 4Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages [J]. J Thorac Cardiovasc Surg, 2000,120(5): 999- 1005.
  • 5Barbero A, Benelli R, Minghelli S, et al. Growth factor supplemented matrigel improves ectopic skeletal muscle formation-a cell therapy approach [J]. J Cell Physiol, 2001,186(2) : 183- 192.
  • 6Naito Y, Imai Y, Shin'oka T, et al. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation [J]. J Thorac Cardiovasc Surg, 2003,125(2):419- 420.
  • 7Williams C, Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries [ J ]. Tissue Eng, 2004, 10 (5/6) : 930 - 941.
  • 8Matsumura G, Miyagawa-Tomita S, Shin'oka T, et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo [J ]. Circulation, 2003,108(14) : 1729 - 1734.
  • 9Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells [ J ]. Ann Surg, 2005,241(3) :506 - 515.
  • 10Suciu A, Civelekoglu G, Tardy Y, et al. Model for the alignment of actin filaments in endothelial cells subjected to fluid shear stress [J]. Bull Math Biol, 1997,59(6) : 1029 - 1046.

共引文献11

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部